|
Effects of the intervention on study outcomes |
|||||
| Baseline survey |
Baseline survey |
Follow-up survey |
Follow-up survey |
p§ |
|
|
|
|||||
| Intervention (n = 542) |
Control (n = 541) |
Intervention (n = 496) |
Control (n = 510) |
||
|
|
|||||
| Anaemia* (%) |
152 (28) |
162 (30) |
83 (17) |
74 (15) |
0.32 |
| Fever prevalence** (%) |
201 (37) |
189 (35) |
143 (29) |
142 (28) |
0.40 |
| Falciparum malaria prevalence*** (%) |
87 (16) |
85 (16) |
64 (13) |
71 (14) |
0.45 |
| Spleen enlargement**** (%) |
108 (20) |
79 (15) |
22 (4) |
19 (4) |
0.08 |
| P. falciparum parasitaemia (%) |
455 (84) |
438 (81) |
379 (76) |
366 (72) |
0.05 |
| Range |
80–100.000 |
40–129.000 |
50–180.000 |
100–108.000 |
|
| Median P. falciparum |
5.000 |
5.000 |
3.000 |
3.000 |
|
| Median haematocrit (range) |
28 (12–40) |
28 (14–40) |
30 (16–42) |
30 (10–40) |
|
| Median weight (kg) |
11.2 |
11.1 |
11.1 |
11.6 |
|
|
* haematocrit ≤ 24%, ** ≥ 37.5°C, *** ≥ 37.5°C + ≥ 5.000 parasites/μl, ****Hackett ≥ 2, § p-value for effect of intervention on study outcomes adjusted for time, age, weight and ethnic group | |||||
Kouyaté et al. Malaria Journal 2008 7:50 doi:10.1186/1475-2875-7-50 |
|||||